The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Nephrotic Syndrome Market Compare Between 2026 And 2030?
The market size for nephrotic syndrome has shown rapid expansion in recent years. It is projected to increase from $0.96 billion in 2025 to $1.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.6%. The historical growth of this market can be attributed to the high prevalence of diabetes and hypertension, the reliance on steroids for treatment, limited diagnostic awareness, the gradual adoption of dialysis technologies, and the rising incidence of childhood nephrotic syndrome.
The market size for nephrotic syndrome is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $1.58 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.4%. This projected growth is largely due to several factors, including breakthroughs in targeted therapies, the expanding application of precision nephrology, the creation of enhanced dialysis devices, increased funding for innovations in kidney replacement therapy, and the wider integration of molecular diagnostic instruments. Key developments anticipated during this period encompass the increased utilization of immunosuppressive therapies, a heightened need for sophisticated dialysis and kidney support systems, the broader implementation of early diagnostic screening initiatives, the escalating incidence of chronic kidney diseases necessitating treatment, and the broadening application of personalized medicine strategies within nephrology.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp
Which Key Drivers Are Affecting The Nephrotic Syndrome Market Development?
A growing occurrence of kidney diseases is projected to stimulate the expansion of the nephrotic syndrome market in the coming years. Kidney diseases encompass various conditions or disorders that impede the proper functioning of the kidneys, which are crucial organs responsible for filtering waste and excess fluids from the blood. This rising incidence of kidney diseases is attributed to factors such as diabetes, hypertension, obesity, an aging demographic, and evolving lifestyle choices, including high sodium intake and insufficient hydration. Nephrotic syndrome contributes to kidney diseases by causing damage to the glomeruli, which impairs the kidney’s ability to filter waste and retain essential proteins. For instance, in June 2023, according to the Oxford Academic, a UK-based Oxford University Press’s academic research platform, the prevalence of CKD in the UK is projected to rise by 4% from 8.27 million to 8.61 million people between 2022 and 2032, with stage distribution in 2032 expected at 30.36% for stage 1, 21.07% for stage 2, 29.78% for stage 3a, 11.86% for stage 3b, 4.15% for stage 4, and 2.78% for stage 5. Therefore, the increasing incidence of kidney diseases is driving the growth of the nephrotic syndrome market.
How Is Segmentation Applied In The Nephrotic Syndrome Market Segment Analysis?
The nephrotic syndrome market covered in this report is segmented –
1) By Type: Drugs, Devices
2) By Diagnosis Tests: Urinalysis, Glomerular Filtration Rate (GFR), Blood Test, Kidney Biopsy, Computerized Tomography (CT) Scan
3) By Application: Clinics, Hospitals, Specialty Centres, Other Applications
Subsegments:
1) By Drugs: Steroids, Immunosuppressants, Diuretics, ACE Inhibitors
2) By Devices: Dialysis Machines, Peritoneal Dialysis Catheters, Hemodialysis Catheters, Kidney Replacement Therapy Devices
What Trends Are Transforming The Nephrotic Syndrome Market?
Key companies within the nephrotic syndrome market are concentrating on developing advanced formulations, such as loop diuretic injections, to enhance fluid management and diminish edema in patients suffering from nephrotic syndrome. A loop diuretic injection is an injectable drug that prevents sodium and chloride reabsorption in the loop of Henle, thereby stimulating quick urine production. It is utilized to address conditions like acute pulmonary edema, heart failure, and severe hypertension by reducing fluid overload. For example, in March 2024, Avenacy Inc., a US-based pharmaceutical firm, introduced furosemide for Injection in the U.S., a generic equivalent to Lasix. This product received approval from the Food and Drug Administration for treating edema linked to heart failure, liver cirrhosis, and kidney diseases. Packaged in 25-unit packs of 100 mg/10 mL doses, this launch forms part of Avenacy’s wider strategy to expand its injectable medication portfolio, with plans to release over 20 products in 2024. This medication is indicated for both adults and pediatric patients for managing edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, which encompasses nephrotic syndrome.
Who Are The Companies Participating In The Nephrotic Syndrome Market Environment?
Major companies operating in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd
Get The Full Nephrotic Syndrome Market Report:
https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report
Which Region Is The Leading Market For The Nephrotic Syndrome Market?
North America was the largest region in the nephrotic syndrome market in 2025. The regions covered in the nephrotic syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nephrotic Syndrome Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report
Browse Through More Reports Similar to the Global Nephrotic Syndrome Market 2026, By The Business Research Company
Neonatal Infant Care Market Report 2026
https://www.thebusinessresearchcompany.com/report/neonatal-infant-care-global-market-report
Acute Respiratory Distress Syndrome Ards Market Report
Lower Respiratory Tract Therapeutics Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model